Impact of the extent and location of liver split on future liver remnant hypertrophy after portal vein ligation in a rat model

被引:2
作者
Chen, Xue [1 ]
Zhou, Bo [1 ]
Wu, Shuai [1 ]
Li, Guangyao [1 ]
Ma, Yu [1 ]
Chen, Ping [1 ]
Chen, Geng [1 ]
机构
[1] Army Med Univ, Daping Hosp, Dept Hepatobil Surg, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
STAGED HEPATECTOMY; ALPPS; PARTITION;
D O I
10.1016/j.surg.2024.01.015
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: To investigate the role and mechanism of liver parenchyma transection in accelerating the regeneration of future liver remnants in rats with portal vein ligation (PVL). Methods: Rats were randomly divided into the PVL group (90% PVL at the caudate lobe, right lobe , left lateral lobe and left median lobe), associating liver partition and portal vein ligation for staged hepatectomy (portal vein ligation with complete liver parenchyma transection [ALPPS]) group (90% PVL with 80 to 90% liver parenchyma transection), PVL + partial liver partition (PLP) group (90% PVL with 30 to 50% liver parenchyma transection), PVL + partition in the ligated lobe (PLL) group (90% PVL with 40 to 60% liver parenchyma transection in the portal vein ligated lobe), PVL + partition in the remnant lobe (PRL) group (90% PVL with 40 to 60% liver parenchyma transection in the remnant lobe), PVL + radiofrequency ablation (RFA) group (90% PVL with splenic ablation) and sham operation (sham) group. The animals were killed at 4 time points of postoperative days 1, 3, 5, and 7. Six rats were killed at each time point, with 24 rats in each group. The weights of the future liver remnant and whole liver were measured. Serum alanine aminotransferase, aspartate aminotransferase, and total bilirubin were analyzed by using an automatic biochemical analyzer. Serum tumor necrosis factor - a , interleukin-6, and hepatocyte growth factor were measured by enzyme -linked immunosorbent assay. The expression of cell proliferating nuclear antigen (Ki67) and phosphorylated histone H3 was detected by immunohistochemistry, and the positive rate was calculated. Results: The ALPPS group displayed the highest FLR weight to body weight ratio compared with that of the other groups ( P < .05), and the partial liver split (PVL + PLP) group also displayed higher remnant weight to body weight ratio than the ectopic liver split (PVL + PLL and PVL + PRL) groups ( P < .05). During the first 7 days after surgery the cytokine levels of the ALPPS, PVL + PLP, PVL + PLL and PVL + PRL groups were comparable ( P > .05). The PVL + PLP, PVL + PLL, PVL + PRL and PVL + RFA groups showed similar necrotic areas in the portal vein ligated lobe ( P > .05). A hemodynamic study revealed that a liver split along the demarcation line could further increase the portal pressure of the FLR and both the split site and completeness were associated with portal hemodynamic alternations and liver hypertrophy. Extrahepatic organ injury (eg, spleen ablation) also has a signi ficant impact on portal hemodynamics and liver regeneration. Conclusion: Complete liver splitting along the demarcation line induced higher portal vein pressure and more rapid FLR hypertrophy than partial or ectopic liver splitting after PVL. The portal hemodynamic alterations after liver split rather than in flammatory cytokine release may be the major cause of ALPPSinduced rapid liver hypertrophy. (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页码:1321 / 1328
页数:8
相关论文
共 50 条
  • [1] Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
    Kremer, Michael
    Manzini, Giulia
    Hristov, Branimir
    Polychronidis, Georg
    Mokry, Theresa
    Sommer, Christoph M.
    Mehrabi, Arianeb
    Weitz, Juergen
    Buechler, Markus W.
    Schemmer, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (03) : 717 - +
  • [2] In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection
    Lehwald-Tywuschik, Nadja
    Vaghiri, Sascha
    Esch, Jan Schulte Am
    Alaghmand, Salman
    Klosterkemper, Yan
    Schimmoeller, Lars
    Lachenmayer, Anja
    Ashmawy, Hany
    Krieg, Andreas
    Topp, Stefan A.
    Rehders, Alexander
    Knoefel, Wolfram Trudo
    BMC SURGERY, 2020, 20 (01)
  • [3] Impact of sarcopenia on the future liver remnant growth after portal vein embolization and associating liver partition and portal vein ligation for staged hepatectomy in patients with liver cancer: A systematic review
    Wang, Qiang
    Wang, Anrong
    Li, Zhen
    Sparrelid, Ernesto
    Brismar, Torkel B. B.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Correlation between the liver transection line localization and future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy
    Romic, Ivan
    Augustin, Goran
    Pavlek, Goran
    Kresic, Elvira
    FRONTIERS IN SURGERY, 2024, 11
  • [5] Portal vein embolization with absolute ethanol to induce hypertrophy of the future liver remnant
    Santhakumar, Cositha
    Ormiston, William
    McCall, John L.
    Bartlett, Adam
    Duncan, David
    Holden, Andrew
    CVIR ENDOVASCULAR, 2022, 5 (01)
  • [6] Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation
    Zhang, Yuefeng
    He, Xiaoqin
    Ma, Peng
    Xiong, Liangkun
    Bai, Wenhui
    Zhang, Gaoshuo
    Xu, Yangtao
    Song, Wei
    Yu, Kaihuan
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (02) : 393 - 404
  • [7] Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study
    Bjornsson, Bergthor
    Hasselgren, Kristina
    Rosok, Bard
    Larsen, Peter Noergaard
    Urdzik, Jozef
    Schultz, Nicolai A.
    Carling, Ulrik
    Fallentin, Eva
    Gilg, Stefan
    Sandstrom, Per
    Lindell, Gert
    Sparrelid, Ernesto
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 75 : 60 - 65
  • [8] Comparison of portal vein embolization, portal vein ligation, associating liver partition and portal vein ligation for staged hepatectomy in cases with a small future liver remnant: a network meta-analysis
    Huang, Hanchun
    Liu, Wenjun
    Wang, Anqiang
    Bian, Jin
    Wang, Shanshan
    Wu, Liangcai
    Lin, Jianzhen
    Xu, Yiyao
    Sang, Xinting
    Zhao, Haitao
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (04) : 826 - 833
  • [9] Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS
    Lunardi, Alessandro
    Cervelli, Rosa
    Volterrani, Duccio
    Vitali, Saverio
    Lombardo, Carlo
    Lorenzoni, Giulia
    Crocetti, Laura
    Bargellini, Irene
    Campani, Daniela
    Pollina, Luca Emanuele
    Cioni, Roberto
    Caramella, Davide
    Boggi, Ugo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (05) : 789 - 798
  • [10] Simultaneous hepatic and portal vein ligation induces rapid liver hypertrophy: A study in pigs
    Schadde, Erik
    Guiu, Boris
    Deal, Rebecca
    Kalil, Jennifer
    Arslan, Bulent
    Tasse, Jordan
    Olthof, Pim B.
    Heil, Jan
    Schnitzbauer, Andreas A.
    Jakate, Shriram
    Breitenstein, Stefan
    Schlapfer, Martin
    Schimmer, Beatrice Beck
    Hertl, Martin
    SURGERY, 2019, 165 (03) : 525 - 533